Last updated on March 2019

Safety and Efficacy of Humira (Adalimumab) for Hidradenitis Suppurativa (HS) Peri-Surgically (SHARPS Study)

Brief description of study

The objective of this study is to assess the safety and efficacy of adalimumab prior to surgery in subjects with moderate to severe Hidradenitis Suppurativa (HS) who are surgical candidates.

Clinical Study Identifier: NCT02808975

Contact Investigators or Research Sites near you

Start Over

Wallace Medical Group, Inc. /ID# 171289

Beverly Hills, CA United States

Tulane Univ /ID# 168441

New Orleans, LA United States

University of Michigan Hospitals /ID# 200667

Ann Arbor, MI United States

Univ NC Chapel Hill /ID# 168446

Chapel Hill, NC United States

Penn State Hershey Medical Ctr /ID# 168447

Hershey, PA United States

Rhode Island Hospital /ID# 168439

Providence, RI United States

UZ Gent /ID# 150906

Gent, Belgium

York Dermatology Center /ID# 151314

Richmond Hill, ON Canada

Bispebjerg Hospital /ID# 150796

Copenhagen NV, Denmark

Univ Med Center Groningen /ID# 150662

Groningen, Netherlands

Erasmus Medisch Centrum /ID# 150672

Rotterdam, Netherlands

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.